This is the authors' abstract. We don't add key points for this paper.
Objective Patients with hepatic decompensation have multisystem needs, frequent readmission and high mortality. We aimed to assess the clinical and economic impact of LivR Well, a 28-day multidisciplinary, home-based programme for decompensated cirrhosis. Design/Method A randomised controlled trial compared LivR Well (home nursing and physiotherapy; clinic-based hepatologist, dietitian, pharmacist and addiction medicine consultations) to standard, ambulatory care. Both groups were coordinated by a specialised liver nurse with a dedicated mobile phone, and could access a day procedure ward. The primary outcome was 30-day liver-related emergency admissions (LREA). Follow-up was to 12 weeks. Both within-trial and modelled economic evaluations assessed cost-effectiveness. Results A total of 105 patients were randomised (intervention: 54, control: 51). There was no difference in LREA rate in the intervention versus control groups (incident rate ratio 0.92, 95% CI 0.39 to 2.16, p=0.84). The 28-day mortality rate was 0% vs 4% (p=0.70) with no difference in survival to 6 months (HR 0.80, p=0.70). MELD score improved in both groups by a median 3.40 (IQR: 0.70–7.80, p=0.53). Quality of life improved similarly in both groups. LivR Well was not cost-effective in either economic evaluation. Conclusions This study did not demonstrate a reduction in hospital admissions nor cost-effectiveness in the intervention group. The lack of a detectable difference may be related to the enhanced standard of care available to both groups. Future iterations should consider a comparison to true standard ambulatory care and exploration of alternative, patient-centred study endpoints to more completely capture the impact of this model of care. Trial registration number ACTRN12621001703897.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“We hypothesise that the two highest impact components of LivR Well are the hepatology clinical nurse consultant for care coordination, and provision of nutritional supplements and home meal delivery due to the prevalence of both disease-related malnutrition and risk of food insecurity in this vulnerable cohort.”
No takes yet. Share an insight, caveat, or question.
Ngu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: